TOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH
|
|
- Brandon Price
- 6 years ago
- Views:
Transcription
1 Investigators Responsibility #1: Design and Implement Ethical Research Consistent with the Three Ethical Principles Delineated in The Belmont Report. The Belmont Report: Three Basic Ethical Principles: Respect for Persons Individual Autonomy Protection of Individuals with Reduced Autonomy Beneficence Maximize Benefits and Minimize Harms Justice Equitable Distribution of Research Costs and Benefits
2 Investigators Responsibility #2: Comply with all Applicable Federal Regulations Impacting the Protection of Human Subjects. Federal Regulations and Policy: 45 CFR 46-Basic DHHS Policy for Protection of Human Research Subjects; The Common Rule Additional Protections Included in 45 CFR 46: Subpart B: Additional Protections for Pregnant Women, Human Fetuses and Neonates Involved in Research Subpart C: Additional Protections Pertaining to Biomedical and Behavioral Research Involving Prisoners as Subjects Subpart D: Additional Protections for Children Involved as Subjects in Research
3 Investigators Responsibility #2: Comply with all Applicable Federal Regulations Impacting the Protection of Human Subjects. Federal Regulations and Policy: FDA Regulations 21 CFR 50 Protection of Human Subjects (including Informed Consent) 21 CFR 56 Guidance for Institutional Review Boards
4 Investigators Responsibility #2: Comply with all Applicable Federal Regulations Impacting the Protection of Human Subjects. HHS vs. FDA Regulations: Basic Requirements for IRBs and for Informed Consent are congruent. Differences Center on Applicability: HHS Regulations apply to all Tulane University Human Subjects Research FDA Regulations based on use of FDA Regulated Products (Drugs, Devices, Biologics) and apply to all Biomedical Research involving FDA Regulated Products
5 Investigators Responsibility #3: Ensure that all Research Involving Human Subjects is Submitted to and Approved by the Appropriate Institutional Review Board. Definitions: Research-A Systematic Investigation Designed to Develop or Contribute to Generalizable Knowledge Human Subject-A Living Individual about whom an Investigator Conducting Research Obtains Data through Intervention or Interaction with the Individual, or Identifiable Private Information Institutional Review Board (IRB)-A committee charged with the review of human participants research to assure that the rights and welfare of human participants are adequately protected.
6 Investigators Responsibility #3: Ensure that all Research Involving Human Subjects is Submitted to and Approved by the Appropriate Institutional Review Board. Why do we need IRB review? No one can be objective about their own work People underestimate the risks involved in things they are very familiar with People overestimate the benefits of things that are important to them
7 Investigators Responsibility #4: Comply with all Applicable IRB Policies, Procedures, Decisions, Conditions, and Requirements. The IRB Approves Research based on the 7 Criteria for Approval: (45 CFR ) Risks to Subjects are Minimized Risk/Benefit Ratio is Reasonable Equitable Selection of Subjects Informed Consent is sought from each subject (45 CFR ) Informed Consent is appropriately documented (45 CFR ) Provisions for monitoring the data collected for safety Provisions for privacy and confidentiality Provisions for Vulnerable Populations
8 Investigators Responsibility #5: Implement Research as Approved and Obtain Prior IRB Approval For Changes. The Research Team is to follow the IRB Approved Protocol. The Research Team is to use the IRB Approved and Stamped Consent Form. Any Changes must be submitted and approved as an Amendment before put into practice.
9 Investigators Responsibility #6: Obtain Informed Consent and Assent in accord with Federal Regulations and as approved by the IRB. Informed Consent is not a single event or just a form to be signed rather, it is an educational process that takes place between the investigator and the prospective subject. The Basic Elements of the Consent Process include: Full disclosure of the nature of the research and the subject s full participation Adequate comprehension on the part of the potential subjects The subject s voluntary choice to participate
10 Investigators Responsibility #7: Document Informed Consent and Assent in accord with Federal Regulations and as Approved by the IRB. Consent Forms should be written in lay language and at an 8 th grade level for readability. Formatting of a Consent/Assent Form can help with comprehension including headings, indents, bolded type, charts, bulleted lists, etc. To assist with developing a cohesive Consent Form, the Tulane HRPO has developed Biomedical and Social/Behavioral Consent and Assent Templates including all required information. Also, a Glossary of Lay Terms for use in completing Consent Forms is available. These tools can be found on the HRPO website.
11 Investigators Responsibility #8: Report Progress of Approved Research to the IRB, as often and in the manner prescribed by the IRB. Continuing Reviews: An IRB shall conduct continuing review of research at intervals appropriate to the degree of risk, but not less than once per year 45 CFR (e)/21 CFR (e) Continuing Review submissions should be submitted 60 to 30 days prior to expiration of research to avoid a lapse in IRB Approval, as NO RESEARCH ACTIVITY MAY BE CONDUCTED DURING A PERIOD OF LAPSE.
12 Investigators Responsibility #9: Report to the IRB any Injuries, Adverse Events, or other Unanticipated Problems Involving Risks to Subjects or Others, and Protocol Deviations. During the conduct of any Research Protocol, Unanticipated Problems and Protocol Deviations must be reported. Tulane HRPP SOPs Section 8 covers Unanticipated Problems Involving Risk to Subjects or Others and contains the Reporting Requirements. Tulane HRPP SOPs Section 9 covers Protocol Violations, Deviations, and Exceptions and contains the Reporting Requirements. The HRPP Policies can be found on the HRPO Website.
13 Investigators Responsibility #10: Retain Signed Consent Documents and IRB Research Records for at least 3 years past completion of the Research Activity. The Tulane University HRPO recommends that PIs and Research Teams keep a Regulatory Binder for each research study. In an effort to assist PIs and Research Teams with the organization of their Research Studies, a guidance document is available on the HRPO Website with instructions on Creating a Regulatory Binder.
14 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING CLINICAL RESEARCH Overview of Clinical Trials: Research studies involving patients or populations at risk for disease May be directed at questions of causation, prevention, early detection or treatment Designed in a scientific manner and conform to ethical standards To increase knowledge Importance of Clinical Trials: To provide evidence-based patient care or prevention of disease To improve the quality of care
15 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING CLINICAL RESEARCH All Clinical Trials at Tulane University must comply with ICH-GCP Guidelines Good Clinical Practice (GCP) is the international and scientific standard for designing, conducting, recording and reporting trial that involve the participation of human subjects. Compliance with GCP provides public assurance that the rights, safety and well-being of study subjects are protected and consistent with the Declaration of Helsinki. Compliance also ensures that clinical trial data and reported results are accurate and credible.
16 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING CLINICAL RESEARCH Why do we need GCP? International concern for the protection of human subjects involved in research has increased Historical Influences (WWII, vulnerable populations) Need for research to advance medical knowledge Unified to facilitate mutual acceptance of clinical data by regulatory authorities
17 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING CLINICAL RESEARCH The Research Team: A group of people working together in a systematic and scientific manner to establish facts Consists of the PI, Co-Investigators, Clinical Coordinators, Data Managers, Research Pharmacist, Research Subjects, Institutional Review Board (IRB), and Regulatory Bodies Committed to applying the principles of GCP in the conduct of clinical research The Protocol Document: A detailed plan and instructions for the conduct of the clinical trial Guidebook for those involved in the day-to-day care of the patient enrolled on the trial The Research Team should all read and comprehend the Protocol Document. Many errors can be avoided if the entire Research Team shows understanding of the Protocol in its entirety.
18 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING CLINICAL RESEARCH Conclusions: Clinical Trials imply a disciplined approach to the care of patients enrolled on the studies. A Research Team approach is ideal. The PI is ultimately accountable and responsible for the conduct of the clinical trial. The PI should strive to meet the high standards of GCP in order to provide public assurance that the rights, safety and well-being of subjects are protected, data is accurate, and reported results are credible.
Top Ten Investigator Responsibilities When Conducting Human Subjects Research
Top Ten Investigator Responsibilities When Conducting Human Subjects Research Thanks to Ada Sue Selwitz, Univ. of Kentucky and PRIM&R (Public Responsibility in Medicine & Research) Investigator Responsibility
More informationAnnual Research Administrators Symposium IRB Compliance. Thursday, July 31, 2014
Annual Research Administrators Symposium IRB Compliance Thursday, July 31, 2014 Why IRB Compliance Is Required for Grant Submissions Topics to Cover Today What is an IRB? Why IRB review is required? Regulatory
More informationEthical Principles in Clinical Research
Ethical Principles in Clinical Research Christine Grady NIH Clinical Center Department of Bioethics No conflicts of interest. Views presented are mine and do not necessarily represent positions or policies
More informationWCG ACADEMY COURSE OVERVIEW
WCG ACADEMY COURSE OVERVIEW Investigator Course Title Documentation of Informed Consent Duration Ethical Principles Underlying Consent Documentation Long Form Short Form Consent Records Special Considerations
More informationEthical Principles in Clinical Research. Disclaimer. Christine Grady Department of Bioethics NIH Clinical Center
Ethical Principles in Clinical Research Christine Grady Department of Bioethics NIH Clinical Center Disclaimer The views expressed are mine and do not necessarily represent the positions or policies of
More informationAdvocate Health Care Network. Human Research Protection Program. Plan
Advocate Health Care Network Human Research Protection Program Plan Revised October 19, 2014 Page 1 Table of Contents Scope... 3 Purpose... 3 Definitions... 3 Clinical Trial... 3 Engaged in Human Research...
More informationHuman Research Protection Program Plan
Revised January 19, 2018 Table of Contents Human Research Protection Program Plan HRP-101 1/19/2018 2 of 13 Scope... 3 Purpose... 3 Definitions... 3 Agent... 3 Clinical Trial... 3 Engaged in Human Research...
More informationWhat is an IRB (Institutional Review Board)?
What is an IRB (Institutional Review Board)? The Belmont Report The Belmont Report on the Ethical Principles and Guidelines for the Protection of Human Subjects of Research was prepared by the National
More informationS A I N T M A RY S E M I N A RY O C T O B E R 1 9,
IRB BASICS FOR ADMINISTRATORS S A I N T M A RY S E M I N A RY O C T O B E R 1 9, 2 0 1 6 JOHN CARROLL UNIVERSITY Catherine Anson, MA, CRA, CIM Director of Sponsored Research Assistant IRB Chair Carole
More informationInstitutional Review Board. Ensuring that the rights and welfare of participants in research are protected.
Institutional Review Board Ensuring that the rights and welfare of participants in research are protected. Michael Linke, PhD, CIP Presenters Health Science Officer, Veterans Affairs Medical Center Associate
More informationTrends in Oversight of Human Research Protections?
Trends in Oversight of Human Research Protections? Greg Koski, PhD, MD Associate Professor, Harvard Medical School Senior Scientist, James Mongan Institute for Health Policy Former Director, Office for
More informationHuman Subjects Research: IRB Resources
Research Compliance Office Human Subjects Research: IRB Resources Kristin B. Frazier HRPP Educational Specialist IRB Resources June 4, 2008 Topics Stanford Institutional Review Boards (IRB) Charge of IRB
More informationEthical Issues in Clinical Trial & Development of Regulation Policy on Clinical Research
Ethical Issues in Clinical Trial & Development of Regulation Policy on Clinical Research Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities Department
More informationHuman Research Protection Program. Plan
Human Research Protection Program Plan Revised September 6, 2017 HRP-101 9/6/17 2 of 13 Table of Contents Scope... 3 Purpose... 3 Definitions... 3 Agent... 3 Clinical Trial... 3 Engaged in Human Research...
More informationHuman Subjects Protection Program Plan
December 1, 2016 HRP-101 12/1/16 2 of 12 Table of Contents Scope... 3 Purpose... 3 Definitions... 3 Agent... 3 Clinical Trial... 3 Engaged in Human Research... 3 Human Research:... 4 Human Subject as Defined
More informationHuman Research Protection Program. Plan
Human Research Protection Program Plan Dated: September 4, 2014 HRP-101 9/4/2014 2 of 14 Table of Contents Scope... 3 Purpose... 3 Definitions... 3 Agent... 3 Clinical Trial... 3 Engaged in Human Research...
More informationInstitutional Review Board Compliance Elizabeth City State University
Institutional Review Board Compliance Elizabeth City State University Michelle Moore, MBA Research Compliance Officer/IRB Administrator Office of Sponsored Programs, Contracts & Grants 110 McLendon Hall
More informationEthics Committees/IRBs Today: Challenges for Efficiency and Quality
Marjorie A. Speers, Ph.D. President and CEO Ethics Committees/IRBs Today: Challenges for Efficiency and Quality Copyright 2013 AAHRPP All rights reserved Goal Clinical Research Globally Access to patients
More informationINVESTIGATOR HANDBOOK
INVESTIGATOR HANDBOOK INVESTIGATOR HANDBOOK Table of Contents MISSION... 3 FIRST TIME SUBMISSION... 3 EDUCATIONAL REQUIREMENTS... 3 PRINCIPAL INVESTIGATOR NEW STUDY SUBMISSIONS... 4 VULNERABLE POPULATIONS...
More informationHow did it evolve? o Public disasters, serious fraud and abuse of human rights. o Trials of War criminals-nuremberg code 1949
ICH GCP Overview What is ICH? ICH is a joint initiative involving both the regulators and the industry as equal partners in the scientific and technical discussions of the testing procedures which are
More informationResearch Data Sharing and Security: The Challenges We Face. Jon Mark Hirshon, MD, PhD, MPH Senior Vice-Chair Institutional Review Board
Research Data Sharing and Security: The Challenges We Face Jon Mark Hirshon, MD, PhD, MPH Senior Vice-Chair Institutional Review Board start us off with your involvement with the IRB and the data security/privacy
More informationHuman Research Protection Program Policy
Adopted: 11/2005 Revised: 03/2014 Page: 1 of 6 RIGHTS AND RESPONSIBILITIES OF PRINCIPAL INVESTIGATORS IN HUMAN SUBJECTS RESEARCH POLICY Each research study will have a Principal Investigator (PI) and may
More informationHuman Subjects Protection: Training for Research Teams
Human Subjects Protection: Training for Research Teams Walter L. Calmbach MD MPH South Texas Ambulatory Research Network (STARNet) Dept. of Family & Community Medicine Univ. of Texas Health Science Center
More informationEffective Date: April 2014 Revision: September 29, 2017
TITLE: Standard Operating Procedure (SOP) Statement of Authority and Purpose NUMBER: NSHA REB-SOP-1-001 Effective Date: April 2014 Revision: September 29, 2017 Applies To: All REB members and Office Personnel
More informationHuman Subjects Research Policy Update. Naomi Coll Director of Research Policy and Compliance
Human Subjects Research Policy Update Naomi Coll Director of Research Policy and Compliance Major Policy Updates 1. Activities that meet the HHS or FDA definition of human subjects research are subject
More informationHow the Past Influenced Human Research Protection Regulations
How the Past Influenced Human Research Protection Regulations Shirley J. Hicks Director, Division of Education and Development Office for Human Research Protections U.S. Department of Health and Human
More informationThe Role of the IRB in Clinical Trials: What Patients and Families Need to Know. Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation
The Role of the IRB in Clinical Trials: What Patients and Families Need to Know Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation 1 CAC2 Values v Put the children and their families first in
More informationHUMAN RESEARCH PROTECTION PROGRAM PLAN
HUMAN RESEARCH PROTECTION PROGRAM PLAN HRP 101 June 2017 706-542-3199 irb@uga.edu https://research.uga.edu/hso/ Table of Contents Scope... 2 Purpose... 2 Definitions... 2 Agent... 2 Clinical Trial... 2
More informationTitle: IRB Purpose, Principles and Responsibilities Page: 1 of 5
THE NORTH SHORE MEDICAL CENTER Institutional Review Board (IRB) POLICIES AND PROCEDURES IRB Policy Number: 001.2 Title: IRB Purpose, Principles and Responsibilities Page: 1 of 5 Written by: Laura W. Knight,
More informationGood Clinical Practice. Martin Rose, MD, JD February 8, 2018 ASQ
Good Clinical Practice Martin Rose, MD, JD February 8, 2018 ASQ Disclaimer The views expressed in this presentation are those of the presenter and do not necessarily represent the official position of
More informationUniversity of the Virgin Islands Institutional Review Board (IRB) IRB Basics for Social Science Senior Seminar (STT/STX)
University of the Virgin Islands Institutional Review Board (IRB) IRB Basics for Social Science Senior Seminar (STT/STX) Ethics and Human Subject Protections Presented by: Olusola Ewulo, M.S. Director,
More informationInstitutional Review Board
Institutional Review Board Overview & Minimal Risk Research Jon Mark Hirshon, MD, MPH Vice-Chairman University of Maryland Institutional Review Board May 18, 2006 Jon Mark Hirshon, MD, MPH 1 Presentation
More informationHuman Research Protection Program. Investigator Manual
Human Research Protection Program Revised July 7, 2014 HRP-910 7/7/2014 2 of 10 Table of Contents What is the purpose of this manual?... 3 What is Human Research?... 3 What is the Human Research Protection
More informationProtection of Research Participants: The IRB Process and the Winds of Change
Protection of Research Participants: The IRB Process and the Winds of Change Ethics in Patient-Oriented Research October 12, 2011 Sharon Friend Director, OHRPP Overview Charge and Function of the IRB Quick
More information1 The Clinical Research Coordinator (CRC)... 1
TABLE OF CONTENTS Dedication... iii Introduction... xi 1 The Clinical Research Coordinator (CRC)... 1 Role and Responsibilities of the CRC...1 Personality and Skills... 3 Where Do CRCs Work?... 3 CRC Responsibilities...
More information\\NAS1\George\Docs\SoCRA\CCRP communications\study guide management
Five Content Areas Percent of Scored Test Items (Range) in Each Area This table shows the percent of scored test questions that are included in each major content area. Five Content Areas Ethical Principles
More informationHuman Research Protections Program Policies and Standard Operating Procedures
Human Research Protections Program Policies and Standard Operating Procedures Version Date: April 2018 Presbyterian Healthcare Services Human Research Protections Office and Institutional Review Board
More informationResearch: Ethics, Informed Consent, FDA, Off Label Use
Research: Ethics, Informed Consent, FDA, Off Label Use Nasim Hedayati, MD, FACS, RPVI Assistant Professor Division of Vascular and Endovascular Surgery University of California, Davis 2015 Phlebology Review
More informationInstitutional Review Board
Institutional Review Board Policies and Procedures for the Protection of Human Subjects in Research Naval Medical Research Center Research Services Directorate Office of Research Administration Code 025,
More informationIRB HUMAN SUBJECTS PROTECTION PROGRAM STANDARD OPERATING PROCEDURES INSTITUTIONAL REVIEW BOARD
IRB INSTITUTIONAL REVIEW BOARD HUMAN SUBJECTS PROTECTION PROGRAM STANDARD OPERATING PROCEDURES REVISED: OCTOBER, Table of Contents Page # INTRODUCTION... 1 CONTACT INFORMATION... 2 PRINCIPLES, ROLES AND
More informationRules of Human Experimentation
Rules of Human Experimentation Elaine Larson CUMC IRB Chair Associate Dean for Research, School of Nursing Professor of Epidemiology, Mailman School of Public Health Oversight for Human Research Office
More informationPREP Course 24: Defining the Differences between FDA and OHRP regulations. Presented by: Hallie Kassan Dorean Flores Office of the IRB
PREP Course 24: Defining the Differences between FDA and OHRP regulations Presented by: Hallie Kassan Dorean Flores Office of the IRB CME Disclosure Statement The North Shore LIJ Health System adheres
More informationApplicability of US Regulations to Canadian Research
Applicability of US Regulations to Canadian Research Mary Kate Needler Capital District Health Authority Halifax, Nova Scotia, Canada N2 Stakeholder Meeting August 18, 2014 MK s Conventions: 1. US Regulation
More informationICH GCP E6(R2): Changes? Yes Challenges? Not as Difficult as You May Fear Lorrie D. Divers, President QRCP Solutions, Inc.
ICH GCP E6(R2): Changes? Yes Challenges? Not as Difficult as You May Fear Lorrie D. Divers, President QRCP Solutions, Inc. 25 October 2017: University of Rochester Achieving High Quality Clinical Research
More information2013 Metrics on Human Research Protection Program Performance
2013 Metrics on Human Research Protection Program Performance Updated August 1, 2014 About the Metrics Improving the quality of human research protection programs (HRPP) is a top priority of AAHRPP. Effective
More informationCompliance and Quality Monitoring: What, Why, When, and How
Compliance and Quality Monitoring: What, Why, When, and How Jeanna Julo, BA, BA, CCRP Assistant Director, Clinical Data Management & Quality Controls, Auditing & Training Research Institute, University
More informationStandard Operating Procedures Guidelines for Good Clinical Practice
SOP # CRSC-105 Effective Date 10-22-2013 Version # 1 Version Date 7-30-2013 Standard Operating Procedures Guidelines for Good Clinical Practice Purpose: This SOP outlines the steps required to follow FDA
More informationGW Policy on Human Research Protection Program
GW Policy on Human Research Protection Program 1. PURPOSE 1.1. This policy establishes the [Organization] s Human Research Protection Program (HRPP) and its commitment to protect the rights and welfare
More informationInstitutional Review Board (IRB)
Institutional Review Board (IRB) Melissa Miklos Program Manager miklosm@upmc.edu Institutional Review Board What is the IRB? Why does the IRB exist? Where is the IRB? Who is the IRB? When do you need the
More informationNorthwestern University HSPP Policy Manual Page 2 of 116
Northwestern University HSPP Policy Manual Page 2 of 116 POLICY FOR HUMAN SUBJECTS RESEARCH AT NORTHWESTERN UNIVERSITY 8 I. PREAMBLE: 8 II. OVERVIEW OF THE IRB, OPRS, AND THE HUMAN SUBJECT PROTECTION PROGRAM
More informationInvestigator Manual. Human Subjects Protection Program
Human Subjects Protection Program HRP-103, Revised June 1, 2015 HRP-103 06/01/2015 2 of 33 Table of Contents Scope... 3 What is the purpose of this manual?... 3 What is Human Research?... 3 What is the
More informationClinical Research with Drugs/Biologics and Devices & Good Clinical Practices
Clinical Research with Drugs/Biologics and Devices & Good Clinical Practices Jason Jobson, BLS, CCRP Research Compliance Officer Oklahoma City VA Medical Center October 2017 Goals Investigational New Drug
More informationCHECKLIST: Pre-review
11-5-2014 1 of 5 The purpose of this checklist is to provide support for IRB staff conducting pre-review. This checklist is to be completed by the IRB staff, signed, dated, and retained with the IRB protocol
More informationHCCA Compliance Institute
HCCA Compliance Institute Implementing a Clinical Research Compliance Program Kendra Dimond, Partner Epstein Becker & Green Washington, DC 202-861-0900 F. Lisa Murtha, J.D. Chief Audit and Compliance Officer
More informationDeveloping and Implementing Standard Operating Procedures
Developing and Implementing Standard Operating Procedures L A U R A T U T T L E, M A, C C R P U N C T R I A L I N N O V A T I O N U N I T P R O G R A M M A N A G E R NC T R A C S I N S T I T U T E Objectives
More informationElyse I. Summers, J.D. President and CEO. Copyright 2018 AAHRPP All rights reserved.
Overcoming Challenges Faced by International IRBs Sharing of Best Practices Among IRBs: Breakout 6 Inaugural Singapore Research Ethics Conference March 1-2, 2018 Singapore Elyse I. Summers, J.D. President
More informationEthical Issues, Community Perspective and Standards of Care for Clinical Research on Women & Children in Africa
Ethical Issues, Community Perspective and Standards of Care for Clinical Research on Women & Children in Africa Holly Rawizza, M.D. Harvard PEPFAR Nigeria/APIN Plus ICASA Dakar, Senegal 3 December 2008
More informationQuality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework
1 Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework Mandy Morneault Research Compliance Monitor University of Washington Institute of Translational Health
More informationConducted Under an IND to Support a
Using Foreign Clinical Trial Data not Conducted Under an IND to Support a US Application PDA Midwest Chapter Meeting March 15, 2018 2013 2017 Regulatory Compliance Associates Inc. All Rights Reserved.
More informationRadiation - Florida Department of Health Institutional Review Board
500-26 Radiation 500-26 Radiation - Florida Department of Health Institutional Review Board Protocol title: Researcher: Application contact: For questions, concerns, to provide input, or request a consultation,
More informationProtocol Submission Form
Protocol Submission Form 1. Administrative Information Name of Submitting Party: Street: Province/State: Postal/Zip Code: Phone: ( ) E-mail Address: Fax: ( ) Other: ( ) Date: 2. General Study Information
More informationEthical Oversight of Human Subject Research. Susan Burner Bankowski, MS,JD OHSU IRB Chair Director, Research Ethics Program
Ethical Oversight of Human Subject Research Susan Burner Bankowski, MS,JD OHSU IRB Chair Director, Research Ethics Program Mandate of the IRB Review all research involving human subjects performed by OHSU
More information1 Human Subjects Protection Training Manuel
1 Human Subjects Protection Training Manuel Human Subjects Protection: Training for Research Teams Brought to you by: Walter L. Calmbach MD MPH South Texas Ambulatory Research Network (STARNet) Dept. of
More informationMCW Office of Research Standard Operating Procedure
MCW Office of Research Standard Operating Procedure USE AND STORAGE OF INVESTIGATIONAL DRUGS AND BIOLOGICS Unit: Applies to: Human Research Protections Program (HRPP), Office of Research MCW/FH Faculty
More informationGCP Basics - refresher
p. 01 GCP Basics - refresher Agenda: p. 02 Brief History of GCP GCP Regulations Principles of ICH E6 Sponsor Responsibilities Computer Systems Common Compliance Issues Brief History of GCP 3 Brief History
More informationExpedited Review of Human Subject Research
Expedited Review of Human Subject Research Table of Contents Eligibility for Expedited Review Expedited Review IRB Oversight of Expedited Review Research Categories Eligible for Expedited Review Review
More informationPARTICIPANT RIGHTS AND PRIVACY. Tammy Stewart, CHRC & Jenny Bernhard, CHPC, CHC
PARTICIPANT RIGHTS AND PRIVACY Tammy Stewart, CHRC & Jenny Bernhard, CHPC, CHC Presentation Outline By the end of this presentation, you will have an understanding of: The history which lead to current
More informationHuman Subjects Research. Kelley A. O Donoghue, MPH, CIP Director Office for Human Subject Protection
Human Subjects Research Kelley A. O Donoghue, MPH, CIP Director Office for Human Subject Protection kelley_odonoghue@urmc.rochester.edu Belmont Report Respect for Persons (Autonomy) Informed Consent Protect
More informationHuman Research Protection Program Education Plan
Human Research Protection Program Education Plan May 1, 2016 Human Research Protections Program e 1313 21 st Ave. South, Room 504 Oxford House, Nashville, Tennessee 37232-4315 e phone 615-322-2918 e fax
More informationResearch Professionals Network Workshop Series
Research Professionals Network Workshop Series SO YOU THINK YOU KNOW GCP? Mary-Tara Roth Director, CRRO mtroth@bu.edu Gina Daniels Human Research Quality Manager gdaniels@bu.edu What is [ICH] GCP? an
More informationHuman Research Protection Program Guidance for Human Research Determination
Human Research Protection Program Guidance for Human Research Determination I.1.A The sole purpose of the Institutional Review Board (IRB), as defined in federal statutes, is the protection of human subjects
More informationRegulatory Protection of Human Subjects in Research
Chapter 2 Chapter Overview The protection of human subjects in research is paramount to any research effort. Research that involves human subjects is highly regulated by federal, state, and institutional
More informationSITE SUBMISSION FORM (SINGLE SITE)
*We accept study submissions by email, fax or mail. 1. STUDY INFORMATION A. Sponsor: Protocol.: Study Title: B. Study Type: Drug, Biologic or Dietary Supplement (please complete section C., then proceed
More informationHANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP)
HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) GUIDANCE FOR IMPLEMENTATION HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) GUIDANCE FOR IMPLEMENTATION WHO Library Cataloguing-in-Publication Data
More informationGood Clinical Practice Handbook
Division of Microbiology and Infectious Diseases Good Clinical Practice Handbook National Institute of Allergy and Infectious Diseases National Institutes of Health Department of Health and Human Services
More informationRegulatory Documentation and Submissions for C2012 Clinical Trials DCP SOP #1
Regulatory Documentation and Submissions for C2012 Clinical Trials DCP SOP #1 Phone: 650.691.4400 Fax: 650.691.4410 Email: regulatory.ccsainc.com COMPLIANCE & STANDARDIZATION Rationale for Revision of
More informationK E M R I STANDARD OPERATING PROCEDURE FOR ROUTINE AND FOR- CAUSE AUDITS
In Search Of Better Health K E M R I STANDARD OPERATING PROCEDURE FOR ROUTINE AND FOR- CAUSE AUDITS REF NO: KEMRI/SERU/SOP/PI/R&FCAC Version: 1 PAGE: 2 of 10 Document Control Schedule Name of department:
More informationFlorida State University Policy 7-IRB-
Florida State University Policy 7-IRB- Title of Policy: Institutional Review Board Jurisdiction/Applicability Responsible Executive: Gary K. Ostrander Approving Official: Gary K. Ostrander Effective Date:
More informationORIGINATION DATE: 01/01/2011 FINAL APPROVAL DATE: April 30, This procedure applies to all clinical trials conducted at any IASIS Facility.
POLICY TITLE: Following the Research Plan MANUAL NAME: Clinical Operations SECTION (as applicable): Clinical Research POLICY NUMBER: CR 1.2.4 Addendum to Corporate Policy Form Available In I-REPP System
More informationSponsor/Investigator Responsibilities
Sponsor/Investigator Responsibilities Marian Serge, RN Division of Bioresearch Monitoring Office of Compliance Center for Devices and Radiological Health Food and Drug Administration Marian.Serge@fda.hhs.gov
More informationInvestigator Manual HRP-103
HRP-103 Revised October 04, 2016 Table of Contents 1. Introduction... 3 A. Scope... 3 B. Purpose of this manual... 3 C. Where to get additional information and answers to questions... 3 E. Human Research
More informationClinical Trials Management for Molecular Diagnostics. April 2016
Clinical Trials Management for Molecular Diagnostics April 2016 Clinical Operations Responsibilities Accrue samples that have proper informed consent for use Retrospective cohorts Remnant samples Prospective
More informationBasics of Human Subjects Research INSTITUTIONAL REVIEW BOARD OFFICE OF RESEARCH CONTRACTS
Basics of Human Subjects Research INSTITUTIONAL REVIEW BOARD OFFICE OF RESEARCH CONTRACTS Presentation Outline What is human subjects research? What are the reasons for IRB review? What is exempt from
More informationTitle: Review of Medical Devices Page: 1 of 5 Written by:
THE NORTH SHORE MEDICAL CENTER Institutional Review Board (IRB) POLICIES AND PROCEDURES IRB Policy Number: 031.1 Title: Review of Medical Devices Page: 1 of 5 Written by: Approved by: Laura W. Knight,
More information3.1. Overall Principal Investigator (PI), who holds the IDE and/or is the Sponsor
POLICY #: RCO-101 Page: 1 of 11 1. POLICY STATEMENT: An Overall Principal Investigator (PI) who holds an Investigational Device Exemption (IDE) or who is the Sponsor of the research has additional responsibilities
More informationVanessa Laroche, CCRC, CCRA, CIP, CQA Quality Assurance Specialist Technical Resources International (TRI), Inc.
December 8, 2016 C2012 Web Seminar Series Identifying and Reporting Protocol Deviations Vanessa Laroche, CCRC, CCRA, CIP, CQA Quality Assurance Specialist Technical Resources International (TRI), Inc.
More informationEVENT TYPE TIMING REQUIRED FORM
Reportable Events EVENT TYPE TIMING REQUIRED FORM Unanticipated Problem or Adverse Event 10 days Event Reporting Form Death (related) 10 days Event Reporting Form Death (not related) Renewal Summary with
More informationAmanda A. Hastings, MSHL Education Specialist USF Division of Research Integrity & Compliance
Amanda A. Hastings, MSHL Education Specialist USF Division of Research Integrity & Compliance 813-974-5452 Research Ethics: Historical Events Syphilis Study in Tuskegee Begins Inoculation Studies in Guatemala
More information2 : self-directing freedom and especially moral independence 3 : a self-governing state
A Adverse Effect Adverse Event AE Amendment Approve Approve Pending Assent Assurance Authorization Autonomy Unanticipated problem or unfavorable symptom or disease occurring during a clinical study, though
More informationOutline of Discussion
This final rule is intended to better protect human subjects involved in research, while facilitating valuable research and reducing burden, delay, and ambiguity for investigators. These revisions are
More informationQuality Assurance in Clinical Trials
Quality Assurance in Clinical Trials Doctor Catherine CORNU, Lyon clinical Investigation Centre EUDIPHARM December 5th, 2011 1 Introduction: quality in clinical research in human subjects Regulatory requirements:
More informationAdministrative Policies VMC #638.1 and Procedures Manual
Administrative Policies VMC #638.1 and Procedures Manual January 14, 2013 TO: FROM: SUBJECT: REFERENCE: VMC Employees Paul E. Lorenz Chief Executive Officer, SCVMC Research Involving Human Subjects TJC,
More informationImplementing Good Clinical Practice at an Academic Research Institution
Implementing Good Clinical Practice at an Academic Research Institution Maintaining Essential Documents Partners Human Research Quality Improvement (QI) Program Stephen W. Hayes Outline Significance of
More informationINSTITUTIONAL ETHICS REVIEW COMMITTEE GLOSSARY
INSTITUTIONAL ETHICS REVIEW COMMITTEE Adverse events Amendment to the protocol Approval Assent Center for Clinical Trials Clinical research Clinical trials - Any untoward or unfavorable medical occurrence
More informationStandard Operating Procedures (SOPs)
Organizational Strategies for Clinical Trials Standard Operating Procedures (SOPs) SUSAN JACKSON, MPA UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL CENTER FOR GASTROINTESTINAL BIOLOGY AND DISEASE UNC CENTER
More information1. POLICY STATEMENT: 2. BACKGROUND:
POLICY #: RCO-201 Page: 1 of 5 1. POLICY STATEMENT: All Food and Drug Administration (FDA) regulated research conducted under an Investigational New Drug Application (IND) and managed within DF/HCC requires
More informationResearch, Human Subject Protection & Institutional Review Board (IRB) Jed Delmore, MD
Research, Human Subject Protection & Institutional Review Board (IRB) Jed Delmore, MD Please pass the Red Bull! History of Human Subjects Protection Nuremberg Code (1947) Unethical Research in the U.S.
More informationEIGHT BASIC ELEMENTS OF INFORMED CONSENT
1/6 This guidance addresses: o Eight Basic elements of informed consent o Additional elements of informed consent o Other information required by the IRB EIGHT BASIC ELEMENTS OF INFORMED CONSENT Required
More informationSource Documents and Regulatory Binders October 6, 2016
Source Documents and Regulatory Binders October 6, 2016 Lisa Wilson, Regulatory Lead, Clinical Trials Office and Mark Alger, CRC, Clinical Trials Office Essential Documents AKA: the stuff in the Reg Binder
More informationSponsor-Investigator Responsibilities In Clinical Trials
In Clinical Trials Margaret Huber, RN, BSN, CHRC Compliance Manager The lecturer has no conflicts for this presentation 9/23/2015 Objectives Define terms sponsor, investigator, and sponsor-investigator.
More information